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ABSTRACT 
SPERM MITOCHONDRIAL DNA BIOMARKERS AS A MEASURE OF MALE 
FECUNDITY AND OVERALL SPERM QUALITY 
MAY 2020 
ALLYSON J. ROSATI, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor J. Richard Pilsner 
Introduction. Sperm parameter analysis is the standard method of male fecundity 
testing; however, minimal evidence supports associations between individual sperm 
parameters and reproductive outcomes. Our previous work shows strong associations 
between sperm mitochondrial DNA copy number (mtDNAcn) and time-to-pregnancy 
(TTP) in general populations, and between mtDNAcn and fertilization outcomes in 
clinical populations. Thus it is possible for sperm mtDNA biomarkers to act as summary 
measures of semen quality. In this study, we developed a sperm quality index (SQI) from 
semen parameters and compared its ability to measure fecundity to sperm mtDNAcn. 
Methods. We received 384 semen samples from the Longitudinal Investigation of 
Fertility in the Environment Study. Sperm mtDNAcn and mtDNA deletions (mtDNAdel) 
were quantified using a triplex probe-based qPCR method. The SQI was developed by 
ranking and summing select sperm parameters within the study population, including 
sperm concentration, sperm count, normal morphology, high DNA stainability, and DNA 
fragmentation to create a cumulative index. Discrete-time proportional hazards models 
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were used to determine fecundability odds ratios (FOR), indicating associations between 
mtDNAcn, SQI, and TTP. Receiver operating characteristic (ROC) analyses determined 
the validity of the SQI and mtDNAcn as predictors of pregnancy within 12 months. 
Results. The SQI was highly associated with mtDNAcn, both continuously (Spearman 
Rho: -0.487; p-value: <0.001) and in deciles (ANOVA p-value: <0.001). The SQI (FOR: 
1.25; 95% confidence interval (CI): 1.09, 1.43) and mtDNAcn (FOR: 0.754; 95% CI: 
0.657, 0.866) performed similarly in discrete-time survival models and indicated a 
significant decrease and increase in TTP, respectively. MtDNAcn more effectively 
predicted pregnancy within 12 months (AUC: 0.703; 95% CI: 0.617, 0.789) than the SQI 
(AUC: 0.642; 95% CI: 0.531, 0.753). With multiple predictors, mtDNAcn outperformed 
summary models, with addition of the SQI and percent normal morphology minimally 
increasing model efficacy (AUC: 0.718, 95% CI: 0.617, 0.819). 
Conclusion. The association between the SQI and mtDNAcn suggest that mtDNAcn may 
serve as a summary biomarker for overall sperm quality. Neither individual nor summed 
sperm parameters are useful indicators of couple fecundity and reproductive outcomes 
compared to mtDNAcn. These results suggest that mtDNAcn has potential for use as a 
biomarker of fecundity.  
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CHAPTER 1 
INTRODUCTION 
 Infertility effects approximately 15% of couples globally (Jungwirth & 
Giwercman et al., 2012) and is defined as the inability of a sexually active couple to 
achieve pregnancy within 12 months. Clinically, male infertility is determined using 
semen quality measures defined by World Health Organization (WHO) cut points 
(Cooper et al., 2010). Although they are used as the standard measurement of fertility, 
semen parameters have been shown to poorly predict reproductive outcomes and have a 
minimal association with fecundability (Buck Louis et al., 2014; Jungwirth & Giwercman 
et al., 2012). These results emphasize the importance of determining other potential 
biomarkers for male infertility that can better predict reproductive outcomes in both 
clinical and general populations. 
 Recent studies have determined associations between mitochondrial DNA 
(mtDNA) biomarkers and couple fecundity. Elevated mitochondrial DNA copy number 
(mtDNAcn) and mitochondrial DNA deletions (mtDNAdel) were recently associated 
with lower odds of fertilization in a cohort of couples undergoing fertility treatment (Wu 
et al., 2019). This study suggested that mtDNA biomarkers provided an incremental 
predictive ability of fertilization that was independent of semen parameters (Wu et al., 
2019). Additionally, increased sperm mtDNAcn has been associated with a decrease in 
sperm parameters including sperm concentration, sperm count, and progressive motility 
(Song & Lewis, 2008; Zhang et al., 2016). 
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 While there is no known mechanism for the association between mtDNA 
biomarkers, semen parameters, and couple fecundity, the characteristics of mitochondria 
and their importance for sperm motility provide motivation for their study in greater 
depth (Rajender et al., 2010). During spermatogenesis, mitochondria form tight helices at 
the midpiece of the sperm and sperm mtDNAcn is reduced by approximately eight to ten 
fold (Hecht et al., 1984; St John et al., 2010). It is possible that an error in 
spermatogenesis results in an increase in mtDNAcn and a decrease in fertilization ability 
due to the maternal nature of mitochondrial inheritance and the specialized defenses 
deployed to prevent paternal mtDNA inheritance (Al Rawi et al., 2011; St John et al., 
2005; Sutovsky et al., 1999). 
 The search for alternative biomarkers for male fertility bears importance because 
of the recently determined global decline in semen parameters. A meta-regression 
analysis determined that total sperm count and sperm concentration have decreased over 
50% since 1973 among men in developed countries (Levine et al., 2017). The purpose of 
this study was to use data collected from a general population prospective cohort to 
determine if a developed sperm quality index (SQI) could perform as well as mtDNAcn 
as a measure of couple fecundability and as a predictor for reproductive outcomes. As 
there is minimal correlation between individual semen parameters and time-to-pregnancy 
(TTP) (Buck Louis et al., 2014), the SQI consisted of multiple semen parameters 
combined into one cumulative parameter for sperm quality based on WHO dictated cut-
points (Cooper et al., 2010).  
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CHAPTER 2 
METHODS 
2.1 Study Population 
Whole semen samples were provided by the Longitudinal Investigation of 
Fertility in the Environment (LIFE) Study. Details for this study have been previously 
published (Buck Louis et al., 2014). In sum, 501 couples attempting to achieve pregnancy 
were randomly recruited in 16 select counties of Michigan and Texas in the United States 
between 2005 and 2009 (Buck Louis et al., 2014). Eligibility criteria included: 1) in a 
committed relationship and attempting to become pregnant; 2) no contraceptive use for 
>2 months and no injectable contraceptive use in the past year; 3) female partners age 18-
40 and male partners 18 years or older; 4) female’s menstrual cycles between 21-42 days; 
5) an ability to communicate in English or Spanish; 6) no history of prior infertility 
treatment (Buck Louis et al., 2014). Study participants gave informed consent and human 
subjects approval was received from collaborating institutions before data collection. The 
current study consisted of 391 couples with an aliquot of semen available for mtDNA 
quantification and analysis. Seven samples were excluded due to limited sperm DNA 
concentration, resulting in a sample size of 384 couples. 
2.2 Data Collection 
Whole semen samples were collected in the homes of participating males, as 
previously published (Buck Louis et al., 2014). Briefly, males provided a baseline sample 
at study entry and a second sample one month later via masturbation (Buck Louis et al., 
2014). Males were abstinent 2 days prior to sample collection and no lubricants were 
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used (Buck Louis et al., 2014). A detailed account of sperm parameter analysis is 
previously published, including details on the use of computer assisted semen analysis 
(CASA) and the Sperm Chromatin Structure Assay (SCSA) (Buck Louis et al., 2014). 
Time-to-pregnancy (TTP) was defined as the number of completed menstrual cycles 
before a human chorionic gonadotropin (hCG) confirmed pregnancy was determined by 
at-home pregnancy kits provided to participants (Buck Louis et al., 2014). 
2.3 mtDNA Quantification 
Sperm DNA was isolated from whole semen samples (n = 391) according to our 
previously published method (Wu et al., 2015). A one-step 50% gradient centrifugation 
was used to separate sperm from seminal plasma and somatic cells. Sperm was later 
homogenized with 0.2 mm steel beads in RLT buffer (Qiagen, Hilden, Germany) 
containing 50 mM tris(2-carboxyethyl)phosphine (TCEP; Pierce, Rockford, IL) and DNA 
was extracted via silica-column purification. MtDNA quantification was performed using 
a triplex probe-based qPCR assay for which details have been previously published 
(Huffman et al., 2018; Phillips et al., 2014). Mitochondrial DNA copy number 
(mtDNAcn) and mitochondrial DNA deletions (mtDNAdel) were simultaneously 
quantified using target regions in the D-Loop minor arc and in the major arc, 
respectively, using a nuclear RNase P target for reference (Huffman et al., 2018; Phillips 
et al., 2014). 
2.4 Semen Quality Index Development 
R software (R Foundation for Statistical Computing, Vienna, Austria) was used to 
assign a rank to select semen parameters with a value from 1 to 384 within the study 
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population. Samples with the same rank order were assigned the mean value, resulting in 
half measures. Semen parameters were chosen based on those outlined by World Health 
Organization (WHO) semen quality cutpoints (Cooper et al., 2010). Total sperm count, 
sperm concentration, percent normal morphology, percent DNA fragmentation, and 
percent high DNA stainability were ultimately chosen to compose the index. Sperm 
motility was excluded from the index because sperm were frozen for shipping before 
initial sperm motility analysis could be performed (Buck Louis et al., 2014), potentially 
having a negative impact on motility measurement. Following ranking within the study 
population, ranks for each individual parameter were then summed to compose a total 
sperm ranking or sperm quality index (SQI). Total sperm count, sperm concentration, and 
percent normal morphology were ranked from lowest to highest because a higher value in 
these parameters is considered higher quality semen (Cooper et al., 2010). Percent DNA 
fragmentation and percent high DNA stainability were ranked from highest to lowest, 
because high values of these parameters have been associated with undesirable fertility 
outcomes, including increased rates of early abortion and decreased sperm vitality among 
other parameters (Yang et al., 2019). Following assignment of a rank, the values per 
participant were summed to create an SQI that accounted for the combination of these 
parameters. 
 An SQI was also generated for the Sperm Environmental Epigenetics and 
Development (SEEDS) Study, a clinical cohort of couples seeking pregnancy through 
assisted reproductive technologies (ART) at Baystate Medical Center in Springfield, 
Massachusetts, USA (Wu et al., 2019). Inclusion criteria for SEEDS were 1) male 
partners between ages 18 – 55 years old with no history of vasectomy; 2) female partners 
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between 18 – 44 years old; 3) expected delivery at Baystate Medical Center; 4) fresh 
ejaculate sperm sample used for treatment (Wu et al., 2019). The same SQI was 
developed as was for the samples from the LIFE cohort, however percent motile sperm 
was included as a parameter in the SQI for SEEDS samples due to the availability of 
fresh non-frozen ejaculate for analysis, while excluded from the SQI for LIFE samples. 
Additionally, percent DNA fragmentation and percent high DNA stainability data were 
unavailable for SEEDS participants and were not included in the SQI. 
2.5 Statistical Analysis 
Participant characteristics were compared by quartile of mtDNAcn using 
ANOVA or chi-square as appropriate to determine relations. Spearman correlation 
analysis was used as a test for trend. MtDNAcn was right skewed and log (base 10) 
transformed to meet model assumptions. MtDNAdel distribution was approximately 
normal and thus was not transformed. Spearman correlation analysis was used to 
determine associations between mtDNA biomarkers and individual sperm parameters and 
the developed SQI. SQI was analyzed by decile of mtDNAcn using non-parametric 
ANOVA and Spearman correlation for continuous trend. 
Discrete-time proportional hazards models were used to determine fecundability 
odds ratios (FOR) and determine associations between mtDNA biomarkers, SQI, and 
individual sperm parameters with TTP. Unadjusted parameters and z-score adjusted 
parameters were used. When adjusted for covariates such as age, BMI, race and ethnicity, 
and smoking, no variables were observed to represent confounders and thus models were 
run without covariates throughout the study. FOR estimates < 1.0 indicate a lower 
probability of pregnancy and thus longer TTP, while FOR estimates > 1.0 indicate higher 
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probability of pregnancy and shorter TTP. Models were adjusted for left truncation and 7 
participants were excluded from the study for having a TTP of 0 yet never achieving 
pregnancy, indicating a loss to follow-up and resulting in a final sample size of 377 for 
statistical analysis. 
The predictive ability of mtDNA biomarkers, the SQI, and individual sperm 
parameters for classifying couple fecundity was evaluated using receiver operating 
characteristic (ROC) curve analysis. Area under the curve (AUC) was used to quantify 
predictive ability in bivariate and multivariate analyses. Models were run using individual 
parameters and using combinations of parameters in order to distinguish those with the 
greatest predictive ability. 
Spearman correlation analysis, ANOVA, and chi-square were performed using R 
(R Foundation for Statistical Computing, Vienna, Austria), while discrete-time 
proportional hazards models and ROC curve analysis were performed using SAS (SAS 
Institute, Cary, North Carolina, USA) 
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CHAPTER 3 
RESULTS 
 
Figure 1. Distribution of sperm mtDNA biomarkers among LIFE male participants 
(n = 384). 
Sperm mtDNAcn was right skewed and log (base 10) transformed to fit model 
assumptions in later analyses, while mtDNAdel fit an approximately normal distribution 
and was not transformed (Figure 1). Participant demographics by quartiles of sperm 
mtDNAcn can be seen in Table 1. Other than mtDNAdel (p<0.001), no characteristics 
were significantly associated with mtDNAcn.  
Table 1. LIFE Study participants (n = 384) by quartile of mitochondrial DNA copy 
number (mtDNAcn). 
        Q1 Q2       Q3       Q4  
Sperm mtDNAcn (0.80 – 2.60) (2.61 – 3.96) (3.98 – 6.38) (6.40 – 61.94)  
                                 Mean (SD) p-value1 p-trend2  
Male age 31.8 (4.1) 31.6 (5.0) 32.1 (4.7) 31.4 (5.2) 0.73 0.53 
Male BMIa 30.2 (5.6) 29.5 (4.9) 29.7 (6.0) 30.3 (6.5) 0.80 0.98 
Sperm mtDNAdel 0.27 (0.09) 0.29 (0.07) 0.33 (0.06) 0.37 (0.06) <0.001 <0.001 
       
Female age 29.6 (3.6) 30.3 (4.5) 30.0 (3.9) 29.8 (4.3) 0.92 0.80 
Female BMIb 28.2 (8.5) 26.4 (6.5) 26.9 (7.2) 28.4 (7.9) 0.77 0.56 
           N (%)  
Male current smokingc  19 (19.8) 16 (16.7) 26 (27.1) 21 (21.9) 0.35 0.14 
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Male raced     0.69 0.70 
     White 80 (83.3) 76 (79.2) 75 (78.1) 80 (83.3)   
     Non-white 15 (15.6) 19 (19.8) 21 (21.9) 16 (16.6)   
       
Female paritye     0.87 0.71 
     Never pregnant 45 (46.9) 37 (38.5) 41 (42.7) 44 (45.8)   
     Pregnant, no birth 8 (8.3) 7 (7.3) 10 (10.4) 9 (9.4)   
     Pregnant, live birth 43 (44.8) 51 (53.1) 45 (46.9) 43 (44.8)   
Abbreviations and Notes: BMI, body mass index; mtDNAdel, mitochondrial DNA 
deletions; 1 p-value determined by ANOVA for continuous variables and chi-square for 
categorical variables; 2 p-trend determined by Spearman correlation analysis; aMissing n 
= 3; bMissing n = 1; cSmoking status determined by a serum cotinine > 10 ng/mL; 
Missing n = 4; dMissing n = 2; eMissing n = 1 
Two versions of the SQI were developed and both behaved similarly in models. 
The SQI consisting of total sperm count, sperm concentration, and percent normal 
morphology based on WHO standards had a minimum of 41.5 and maximum of 1,085. 
The SQI with percent DNA fragmentation and percent high DNA stainability added had a 
minimum of 96.5 and maximum of 1,786. Both SQI (Spearman Rho: -0.491; p-value: 
<0.001) and SQI including fragmentation and stainability (Spearman Rho: -0.487; p-
value: <0.001) were highly associated with mtDNAcn. Both indices were also associated 
with mtDNAdel, (Spearman Rho: -0.271; p-value: <0.001 without fragmentation and 
stainability; Spearman Rho: -0.273; p-value: <0.001 with fragmentation and stainability) 
albeit to a smaller magnitude. Complete Spearman correlation analysis between 
individual parameters and mtDNA biomarkers is detailed in Table 2. 
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SQI including fragmentation and stainability was correlated with continuous 
mtDNAcn assessed via Spearman analysis and also with mtDNAcn in deciles (p-value: 
<0.001) (Figure 2). The SQI developed for the SEEDS cohort had a minimum of 9 and 
maximum of 681.5. Like for LIFE participants, SQI for SEEDS participants was highly 
Table 2. Spearman Rank Correlation between Individual Sperm Parameters 
and Sperm MtDNA biomarkers (n = 384). 
 mtDNAcn mtDNAdel 
Semen Volume (mL) 0.077 0.056 
Sperm Concentration (106/mL) -0.502*** -0.283*** 
Total Sperm Count (106/mL*vol) -0.419*** -0.247*** 
Percent of Live Sperm (%) -0.156** -0.111* 
Average Path Velocity (μm/sec) -0.136** -0.073 
Straight Line Velocity (μm/sec) -0.138** -0.086 
Curvilinear Velocity (μm/sec) -0.101* -0.056 
Amplitude of Lateral Head (μm) -0.088 -0.079 
Beat Cross Frequency (Hz) -0.041 -0.022 
Straightness (%) -0.090 -0.050 
Linearity (%) -0.121* -0.057 
Percent Motility (%) -0.327*** -0.183*** 
Sperm Head Length (μm) 0.137** 0.067 
Sperm Head Area (μm2) -0.032 -0.069 
Sperm Head Width (μm) -0.133** -0.180*** 
Elongation Factor (%) -0.196*** -0.153** 
Sperm Head Perimeter (μm) 0.083 0.037 
Sperm Head with Acrosome (%) -0.168*** -0.019 
Meeting of Strict Morphology Criteria (%) -0.359*** -0.173** 
Meeting of WHO Morphology Criteria (%) -0.366*** -0.180*** 
Amorphous (%) 0.228*** 0.154** 
Round (%) 0.254*** 0.140** 
Pyriform (%) 0.074 0.031 
Bicephalic (%) 0.189*** 0.018 
Taper (%) 0.081 0.027 
Megalohead (%) 0.111* 0.062 
Microhead (%) 0.055 0.048 
Neck and Midpiece Abnormalities (%) 0.303*** 0.112* 
Coiled Tail (%) 0.220*** 0.060 
Other Tail Abnormalities (%) 0.283*** 0.145** 
Cytoplasmic Droplet (%) 0.197*** 0.097 
Immature Sperm (#) 0.485*** 0.206*** 
DNA Fragmentation (%) 0.215*** 0.174*** 
High DNA Stainability (%) 0.264*** 0.122* 
   
Sperm Quality Index -0.491*** -0.271*** 
Sperm Quality Index including Fragmentation and 
Stainabilitya 
-0.487*** -0.273*** 
   
Abbreviations and Notes: mtDNAcn, mitochondrial DNA copy number; 
mtDNAdel, mitochondrial DNA deletions; aMissing n = 3; 
*p < 0.05; **p < 0.01; ***p < 0.001 
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associated with continuous mtDNAcn (Spearman Rho: -0.517; p-value: <0.001) and 
mtDNAcn in deciles (p-value: <0.001) (Figure 2). 
 
Figure 2. Relationship between generated SQI and mtDNAcn in LIFE (left; n=357) and 
SEEDS (right; n=140) cohorts. Continuous trend analyzed by Spearman Correlation 
(LIFE: Rho: -0.487, p < 0.001; SEEDS: Rho: -0.508, p < 0.001) and differences between 
deciles analyzed using non-parametric ANOVA (LIFE: p < 0.001; SEEDS: p < 0.001). 
 Discrete-time proportional hazards models revealed a strong inverse association 
between increasing mtDNAcn and TTP (FOR: 0.754; 95% CI: 0.657, 0.866). SQI 
including fragmentation and stainability was more strongly associated with TTP (FOR: 
1.25 95% CI: 1.09, 1.43) than SQI without these two parameters (FOR: 1.20; 95% CI: 
1.05, 1.38), however both associations were significant. Survival analyses for individual 
parameters used in SQI development can be found in Table 3, with models run using 
unadjusted values and z-score transformed values to account for differences of scale 
between measures. Percent normal morphology was also found to be highly associated 
with TTP, exhibiting an association of similar magnitude to the SQI with fragmentation 
and stainability (FOR: 1.27; 95% CI: 1.11, 1.45). MtDNAdel was not found to be 
associated with TTP. 
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Table 3. Fecundability Odds Ratios (FOR) estimated using Cox Proportional 
Hazards Models relating time to pregnancy (TTP) to sperm mtDNA biomarkers, 
Sperm Quality Index, and specific sperm parameters. 
      Z-Scores      Untransformed Data 
MtDNAcn 0.754 (0.657, 0.866) *** 0.380 (0.237, 0.611)*** 
MtDNAdel 0.908 (0.798, 1.034) 0.306 (0.062, 1.509) 
Sperm Quality Index 1.204 (1.054, 1.376) ** 1.001 (1.000, 1.001)** 
Sperm Quality Index 
including DNA 
Fragmentation and 
Stainability 
1.249 (1.091, 1.430)** 1.001 (1.000, 1.001)** 
Sperm Concentration 1.097 (0.976, 1.233) 1.002 (1.000, 1.004) 
Total Sperm Count 1.171 (1.038, 1.321)* 1.001 (1.000, 1.002)* 
Meeting of WHO 
Morphology Criteria 
1.267 (1.111, 1.445)*** 1.020 (1.009, 1.031)*** 
Neck and Midpiece 
Abnormalities 
0.901 (0.789, 1.030) 0.989 (0.976, 1.003) 
DNA Fragmentation 0.837 (0.727, 0.963)* 0.983 (0.970, 0.996)* 
High DNA Stainability 0.872 (0.758, 1.005) 0.974 (0.948, 1.001) 
Abbreviations and Notes: MtDNAcn, mitochondrial DNA copy number; 
MtDNAdel, mitochondrial DNA deletions; *p < 0.05, **p < 0.01, ***p < 0.001 
 
ROC analysis determined that mtDNAcn had higher predictive ability of 
pregnancy within 12 months (AUC: 0.703; 95% CI: 0.617, 0.789) than any other 
individual parameter and the SQI index both with (AUC: 0.642; 95% CI: 0.531, 0.723) 
and without (AUC: 0.650; 95% CI: 0.547, 0.753) DNA fragmentation and stainability. 
Surprisingly, total sperm count (AUC: 0.674; 95% CI: 0.576, 0.771) was the parameter 
with the strongest predictive ability other than mtDNAcn. However, total sperm count 
was not as strongly associated with TTP (FOR: 1.17; 95% CI: 1.04, 1.32) as morphology 
and the SQI, and was not explored further in later analyses. 
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Figure 3. Receiver Operating Characteristic (ROC) analysis unadjusted for confounding 
variables using mtDNA, sperm quality index, and specific sperm parameters as a 
predictor for pregnancy within 12 months of trying. 
Top row left to right: MtDNAcn; MtDNAdel; Sperm Quality Index; Sperm Quality Index 
including DNA Fragmentation and Stainability; Sperm Concentration 
Bottom row left to right: Total Sperm Count; Meeting of WHO Morphology Criteria; 
Neck and Midpiece Abnormalities; DNA Fragmentation; High DNA Stainability 
*p < 0.05; **p < 0.01; ***p < 0.001 
 
 Using previous results, ROC analyses were performed using multiple predictors 
in an attempt to determine the parameter best able to predict pregnancy within 12 months. 
MtDNAcn, percent normal morphology, and the SQI combined were shown to have the 
strongest predicting power (AUC: 0.718; 95% CI: 0.617, 0.819). However, when 
mtDNAcn was removed and the model consisted only of percent normal morphology and 
the SQI, a large decrease in predictive ability was observed (AUC: 0.661; 0.549, 0.774). 
Additionally, the model consisting of all three parameters exhibited a minimal increase in 
predictive ability in comparison to mtDNAcn alone (AUC: 0.703; 95% CI: 0.617, 0.789). 
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Table 4: Components of Models and Predictive Power of Each Model Suggested 
by AUC of ROC Curve. 
Model mtDNAcn Morphology SQI AUC (95% CI) 
1 X   0.703 (0.617, 0.789) 
2  X  0.654 (0.544, 0.764) 
3   X 0.642 (0.531, 0.753) 
4 X X  0.713 (0.615, 0.812) 
5 X  X 0.700 (0.599, 0.801) 
6  X X 0.661 (0.549, 0.774) 
7 X X X 0.718 (0.617, 0.819) 
Abbreviations and Notes: SQI: Sperm Quality Index with DNA fragmentation 
and stainability; AUC: Area Under Curve; ROC: Receiver Operating 
Characteristic; X indicates parameter included in model. 
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CHAPTER 4 
DISCUSSION 
 The sperm quality index (SQI) both with and without DNA fragmentation and 
high DNA stainability was highly associated with sperm mtDNAcn (p-value: <0.001) 
when assessed both continuously and in deciles (Table 2; Figure 2). While the parameters 
were highly correlated (Table 2; Figure S1; Figure S2), sperm mtDNAcn demonstrated a 
stronger predictive ability for pregnancy within 12 months than the SQI (Figure 3; Table 
4). In magnitude, both mtDNAcn and the SQI were similarly and significantly associated 
with TTP, with an FOR of 0.754 (95% CI: 0.66, 0.87) for mtDNAcn and an FOR of 1.25 
(95% CI: 1.09, 1.43) for the SQI (Table 3). Couples with an elevated sperm mtDNAcn 
exhibited longer TTP while those with an increased SQI exhibited shorter TTP. 
 While the summary SQI consisting of multiple semen parameters exhibited an 
association with couple fecundity (Table 3), individual semen parameters have shown 
poor associations with fecundability in previous work. In a comparison of semen analysis 
results between fertile and infertile couples, none of the individual parameters were 
observed to predict fertility status (Guzick et al., 2001). In this study, percent normal 
morphology exhibited the greatest discriminating ability, but still exhibited strong 
overlap between groups. These findings are consistent with our data in which percent 
normal morphology is associated with TTP (FOR: 1.267; 95% CI: 1.111, 1.445), but is 
not as useful a predictor of pregnancy within 12 months (AUC: 0.654; 95% CI: 0.544, 
0.764) as sperm mtDNAcn (AUC: 0.703; 95% CI: 0.617, 0.789)(Table 3; Figure 3). 
Additionally, in a general population cohort study observing 36 different semen 
parameters and their association with TTP, only one parameter exhibited a significant 
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correlation in multivariable models, while individual model estimates were of extremely 
low magnitude (Buck Louis et al., 2014).  
 In addition to the correlation between mtDNAcn and TTP, previous work has 
established a strong association between mtDNAcn and fertilization rates in couples 
undergoing ART. In a cohort of 119 couples, higher sperm mtDNAcn and mtDNAdel 
were strongly associated with lower fertilization rates and embryo quality (Wu et al., 
2019). Meanwhile, a meta-analysis reported that leukocytospermic men exhibited 
significant decreases in semen parameters, including progressive motility and sperm 
concentration, yet no decrease in fertilization or pregnancy rates were observed when 
these couples sought ART (Castellini et al., 2020). These results indicate a poor 
association between individual sperm parameters and fertilization outcomes in 
comparison to mtDNA biomarkers. 
 While the mechanism underlying the strong association between sperm 
mtDNAcn, semen parameters, and reproductive outcomes is unclear, it is possible that 
sperm mtDNAcn can act as a marker for abnormal spermatogenesis. During 
spermiogenesis, mtDNA is depleted eight to ten fold, thus it is possible that an increased 
sperm mtDNAcn results from an error in this phase of sperm maturation (Hecht et al., 
1984; St John et al., 2010). The strong association observed between semen quality and 
sperm mtDNAcn observed in this study is consistent with this theory (Table 2; Figure S1; 
Figure S2). Furthermore, it is possible that the robust cellular defenses deployed to ensure 
maternal mtDNA inheritance (Al Rawi, et al., 2011, St John, et al., 2005, Sutovsky, et al., 
1999) are partially responsible for the association between elevated sperm mtDNAcn and 
poor fertilization outcomes (Darr et al., 2017; Wu et al., 2019). There is also potential for 
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an elevated sperm mtDNAcn to act as a biomarker for oxidative stress due to the 
susceptibility of sperm mtDNA to oxidative damage because of the role of the 
mitochondrion in ATP production and its proximity to the electron transport chain 
(Phillips et al., 2014). mtDNA also lacks the robust repair mechanisms found in nuclear 
DNA (Phillips et al., 2014). The definitive mechanism remains elusive and further study 
is needed to fully support these notions and to determine the mechanistic link between 
sperm mtDNAcn, semen parameters, and couple fecundity.  
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CHAPTER 5 
CONCLUSION 
 Individual semen parameters are ineffective measures of male fecundity and of 
couples’ reproductive ability, thus determining alternative markers of overall 
reproductive health are of critical importance. Our study provides support to the notion 
that mtDNAcn can serve as an overall biomarker for semen quality and couple fecundity 
as it has a strong association with TTP and outperforms both individual semen 
parameters and our developed cumulative index in predictive ability for pregnancy within 
12 months. This study asserts that sperm mtDNAcn could serve as a useful and more 
accurate single measure parameter for male reproductive health and pregnancy success, 
as well as overall semen quality, in the general population. 
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APPENDIX A 
SUPPLEMENTAL FIGURES 
 
Figure 4. Heatmap indicating Spearman Rank correlation between mtDNA biomarkers, 
individual sperm parameters, and the sperm quality index with (SQI_FragStain) and 
without (SQI) DNA fragmentation and stainability. Colors indicate strength of correlation 
and size indicates significance. Significance level p < 0.05. 
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Figure 5. Heatmap indicating the Spearman Rank correlation between mtDNA 
biomarkers, sperm quality index with (SQI_FragStain) and without (SQI) DNA 
fragmentation and stainability, and individual sperm parameters used to build the SQI. 
Color indicates strength of correlation and size indicates significance. Significance level 
p < 0.05. 
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APPENDIX B 
MITOCHONDRIAL SHEATH LENGTH MEASUREMENT PROTOCOL 
B.1 Introduction 
Sperm mitochondria have a critical role in sperm motility and function, and thus 
have earned attention as potential indicators of male fertility (Rajender et al., 2010). 
During spermatogenesis, the rounded mitochondria elongate and form tight helices within 
the midpiece of the sperm, thus forming the mitochondrial sheath. Previous work has 
determined that a shorter mitochondrial sheath length correlates with lower fertilization 
outcomes in bull sperm (Sutovsky et al., unpublished work). Another study has 
determined the importance of glycerol kinase 2 in the formation of the sperm 
mitochondrial sheath (Shimada et al., 2019). When glycerol kinase 2 function was 
interrupted in mice, sperm mitochondrial sheath length formation during spermatogenesis 
was interrupted and resulted in an infertility phenotype in these mice, suggesting a link 
between proper sheath formation and fertilization ability (Shimada et al., 2019). 
Our previous work has established a negative association between mtDNAcn and 
reproductive outcomes in both clinical populations (Wu et al., 2019) and in the general 
population (Rosati et al., unpublished work). These findings raise the question of what 
other sperm mitochondrial DNA biomarkers are associated with reproductive outcomes. 
As a result, our laboratory has sought to optimize a protocol for the measurement of 
sperm mitochondrial sheath length in human sperm.  
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B.2 Protocol 
B.2.1 Processing 
Reagents: 
Quinn’s Sperm Washing Medium (Cooper Surgical Inc., Trumbull, Connecticut, USA; 
Catalog no. ART-1006) 
PureCeption 100% Isotonic Soluton (Cooper Surgical Inc., Trumbull, Connecticut, USA; 
Catalog no. ART-2100) 
50% PureCeption Mix: 5 mL PureCeption mixed with 5 mL Quinn’s Sperm Washing 
Medium 
1. Allow whole semen to liquefy for 30 minutes at room temperature 
2. Centrifuge semen at 500 g for 10 min 
3. Remove and discard the seminal plasma supernatant 
4. Resuspend the pellet in 1.5 mL of Quinn’s Sperm Washing Medium 
5. Layer the resuspended pellet carefully on top of 1 mL of 50% PureCeption mix 
6. Centrifuge at 500 g for 25 min 
7. Remove pellet and buffer to a final volume of 500 uL 
8. Add pellet and buffer to 2 mL Quinn’s Sperm Washing Medium 
9. Mix by pipetting 
10. Centrifuge at 500g for 5 min 
11. Remove pellet and buffer to a final volume of 1 mL 
12. Store in fridge for later use, if necessary 
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B.2.2 Fixation 
Reagents: 
37% Formaldehyde (Thermo Scientific, Waltham, Massachusetts, USA) 
10X PBS (Applied Biosystems, Foster City, California, USA) 
1X PBS: 1 mL 10X PBS mixed with 9 mL deionized (DI) water 
4% Formaldehyde: 500 uL 37% formaldehyde mixed with 4.5 mL 1X PBS 
1. Add processed sperm dropwise in 1 mL 4% formaldehyde 
2. Invert tube five times to mix 
3. Incubate 30 min at room temperature 
4. Centrifuge formaldehyde/sperm mixture at 600 g for 15 min 
5. Pour off supernatant as much as possible and resuspend pellet in remainder 
6. Add 1 mL 1X PBS to resuspend sample 
7. Store in fridge for later use, if needed 
 
B.2.3 Counting 
1. Dilute 3 uL of fixed sample in 27 uL of 1X PBS (dilution factor (DF) = 10) 
2. Add 10 uL of diluted fixed sample to each side of the hemocytometer and let 
stand several minutes 
3. Count five 0.2 mm by 0.2 mm squares on each side of hemocytometer 
4. Sum counts and determine an average sperm count per side of the hemocytometer 
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5. Concentration = average * 5 (to represent squares not counted) * DF * 10,000 
(volume of hemocytometer) 
 
B.2.4 Staining 
Reagents: 
10X PBS (Applied Biosystems, Foster City, California, USA) 
1X PBS: 1 mL 10X PBS mixed with 9 mL DI water 
Ethylenediaminetetraacetic acid (EDTA) (Fisher Scientific, Waltham, Massachusetts, 
USA) 
Triton X-100 (Fisher Bioreagents, Waltham, Massachusetts, USA) 
Hoechst 33342 Nuclear Stain (Enzo Life Sciences, Inc., Farmingdale, New York, USA; 
Catalog no. ENZ-51035-K100) 
MitoView Green (Biotium, Fremont, California, USA; Catalog no. 70054) 
Dimethyl Sulfoxide (DMSO) (Sigma Aldrich, St. Louis, Missouri, USA) 
Permeabolizing Solution: 4.945 mL 1X PBS mixed with 30 uL EDTA and 25 uL Triton 
X-100 
1. Centrifuge fixed sperm at 600 g for 15 min 
2. Remove supernatant and resuspend pellet in remainder 
3. Add resuspended pellet dropwise to 1 mL permeabolizing solution 
4. Incubate on ice for 30 min 
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5. Centrifige at 600 g for 15 min 
6. Remove supernatant and resuspend pellet in remainder 
7. Add 500 uL 1X PBS to resuspended pellet and mix via pipetting 
8. Centrifuge at 600 g for 15 min 
9. During spin, prepare desired dye concentrations  
a. Hoechst 33342: 
i. add 1 uL to 99 uL 1X PBS 
b. MitoView Green: 
i. Make 200 uM stock by adding 50 ug dye to 400 uL DMSO 
ii. Create a 100 uM solution by diluting 200 uL of the  200 uM 
solution in 200 uL DMSO.  
iii. Add 1 uL of the 100 uM stock to 9 uL of DMSO to create a 10 uM 
solution. 
10. Remove supernatant and resuspend pellet in 500 uL 1X PBS 
11. Add 1 uL of each diluted stain to sperm 
12. Incubate in dark box for 30 min at room temperature 
13. Centrifuge at 600 g for 15 min 
14. Remove supernatant and resuspend pellet in 50 uL of 1X PBS 
 
B.2.5 Polylysine Treatment: 
Reagents: 
Poly-L-lysine (Sigma Aldrich, St. Louis, Missouri USA; Catalog no. P4707-50ML) 
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1. Using 1 mL poly-L-lysine per 25 cm2, coat coverslips by pipetting onto coverslip 
and rocking the liquid back and forth to coat the entire surface 
a. Use 500 uL of poly-L-lysine 
2. Overturn coverslips into excess poly-L-lysine for complete coating 
3. Allow to soak for 5 min 
4. Remove poly-L-lysine via aspiration 
5. Rinse coverslips thoroughly with deionized (DI) water 
6. Allow coverslips to dry for at least 2 hours 
 
B.2.6 Imaging: 
1. Add 10 uL stained sample to each slide and cover with poly-L-lysine treated 
coverslips 
2. Tape coverslips to slide 
3. Transfer to microscopy core in dark box to minimize light exposure 
4. Place slide coverslip-down on microscope stage 
5. Using 60x objective of A1-Resonant Scanning Confocal Microscope with TIRF 
Module (Nikon Instruments, Melville, New York, USA), locate and focus sperm 
6. Use automated microscope function to image sperm in a 0.1 mm radius on slide 
area 
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B.2.7 Data Analysis: 
1. Use NIS-Elements AR software (Nikon Instruments, Melville, New York, USA) 
to detect midpieces of sperm cells based on fluorescence intensity of MitoView 
Green and proximity to Hoechst 33342 stain 
2. Once detected, use template to measure midpieces at the longest point 
3. Export sheath measurements to spreadsheet for future analysis 
 
B.3 Significance and Future Directions 
 When this protocol is fully optimized, it will be possible to use LIFE semen 
samples to determine any possible correlation between sperm mitochondrial sheath length 
and time-to-pregnancy (TTP) using discrete-time proportional hazards model. 
Additionally, it will be possible to test the functionality of sheath length as a predictor for 
couple fecundity by using receiver operating characteristic (ROC) analysis of 
mitochondrial sheath length with occurrence of pregnancy within 12 months. The 
potential for mitochondrial sheath length to serve as another biomarker for male and 
couple fecundity is of importance because of the poor association between sperm 
parameters and reproductive outcomes (Buck Louis et al., 2014; Wu et al., 2019; Guzick 
et al., 2001). If any association is determined, it would be possible to combine the 
predictive abilities of sperm mtDNAcn and mitochondrial sheath length to measure 
overall semen quality in the general population. However, for this study to continue, 
changes to the above protocol must be made. 
In terms of imaging, problems with automated sheath detection are hindering 
results. The automated sheath detection template must be calibrated further to detect only 
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the midpiece of the sperm and to ignore any non-specific staining in other regions of the 
sperm or throughout the buffer. For this, it could be advisable to use a stained control, 
containing only buffer with no sperm, and determine an adequate method for eliminating 
background fluorescence from sample images. Rather than eliminating non-specific 
staining post-imaging, it could be possible to ensure more specific staining through the 
use of antibodies for mitochondrial detection in the staining process. 
Cellular aggregates and non-specific staining are key issues with the automated 
detection template. The treatment of coverslips with poly-L-lysine has decreased 
aggregates within the sample by creating a single layer of cells, however aggregates are 
still present. It could be beneficial to use a well and three dimensional droplet of sample, 
rather than a flat coverslip, and to allow the sperm to settle into a single layer. This would 
require re-optimization of the imaging protocol because it is unknown how long the 
sample would need to rest in order for cells to settle into a single layer without the use of 
a coverslip. To eliminate aggregates without re-optimizing the protocol, post-processing 
filters can be deployed; however, circularity filters have been ineffective in removing 
undesirable aggregates and another method has yet to be determined. 
Finally, to improve statistical power of these assessments, it is necessary to image 
more sperm and increase sample size. The automated imaging of the A1R-TIRF 
microscope (Nikon Instruments, Melville, NY) can only produce a limited number of 
images per slide, after which the stains are photo-bleached and a new slide must be 
prepared. Samples should likely be run in triplicate in order to obtain maximum sheath 
measurements due to limited imaging capacity and the necessary filters that eliminate 
select sperm cells from measurement. 
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While many changes remain to be made to this protocol, determining any existing 
correlation between mitochondrial sheath length and reproductive outcomes is of 
importance due to the unknown nature of idiopathic male infertility and the unknown 
mechanism underlying the association between mtDNAcn and male fecundity. If an 
association exists between mitochondrial sheath length and male fecundity, it could 
provide an underlying mechanism for male infertility such as abnormal spermatogenesis 
and disruption of sperm mitochondrial sheath formation (Shimada et al., 2019). 
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